Literature DB >> 25386573

Soluble mediators in posttraumatic wrist and primary knee osteoarthritis.

Teun Teunis1, Michiel Beekhuizen1, Gerjo V M Van Osch1, Arnold H Schuurman1, Laura B Creemers1, L Paul van Minnen1.   

Abstract

BACKGROUND: New discoveries about the pathophysiology changed the concept that all forms of osteoarthritis are alike; this lead to the delineation of different phenotypes such as age, trauma or obese related forms. We aim to compare soluble mediator profiles in primary knee and posttraumatic wrist osteoarthritis. Based on the general faster progression rate of wrist osteoarthritis, we hypothesize a more inflammatory profile.
METHODS: We collected synovial fluid from 20 primary osteoarthritic knee and 20 posttraumatic osteoarthritic wrist joints. 17 mediators were measured by multiplex enzyme-linked immunosorbent assay: chemokine ligand 5, interferon-γ, leukemia inhibitory factor, oncostatin-M, osteoprotegerin, tumor necrosis factor-α, vascular endothelial growth factor, interleukin (IL)-1α, IL-1β, IL-1 receptor antagonist, IL-4, IL-6, IL-7, IL-8, IL-10, IL-13 and IL-17.
RESULTS: TEN MEDIATORS WERE HIGHER IN POSTTRAUMATIC OSTEOARTHRITIC SYNOVIAL FLUID: tumor necrosis factor-α (TNFα), IL-1α, IL-1RA, IL-6, IL-10, IL-17, oncostatin-M, interferon-γ, chemokine ligand 5 and leukemia inhibitory factor (P<0.001). IL-1ß, IL-4, IL-7 were not detected, TNFα was not detected in knee osteoarthritic synovial fluid. IL-8, IL-13, osteoprotegerin and vascular endothelial growth factor levels did not differ between the synovial fluid types.
CONCLUSIONS: In general wrist osteoarthritis seems characterized by a stronger inflammatory response than primary knee osteoarthritis. More pronounced inflammatory mediators might offer a paradigm for the faster progression of posttraumatic osteoarthritis. Increase of specific mediators could form a possible target for future mediator modulating therapy in wrist osteoarthritis.

Entities:  

Keywords:  Cytokines; Knee; Osteoarthritis; Posttraumatic; Wrist

Year:  2014        PMID: 25386573      PMCID: PMC4225017     

Source DB:  PubMed          Journal:  Arch Bone Jt Surg        ISSN: 2345-461X


  22 in total

Review 1.  Articular fractures: does an anatomic reduction really change the result?

Authors:  J L Marsh; J Buckwalter; R Gelberman; D Dirschl; S Olson; T Brown; A Llinias
Journal:  J Bone Joint Surg Am       Date:  2002-07       Impact factor: 5.284

2.  Improved multiplex immunoassay performance in human plasma and synovial fluid following removal of interfering heterophilic antibodies.

Authors:  Wilco de Jager; Berent J Prakken; Johannes W J Bijlsma; Wietse Kuis; Ger T Rijkers
Journal:  J Immunol Methods       Date:  2005-05       Impact factor: 2.303

3.  Cytokine multiplex immunoassay: methodology and (clinical) applications.

Authors:  Wilco de Jager; Berent Prakken; Ger T Rijkers
Journal:  Methods Mol Biol       Date:  2009

4.  Synovial fluid--its mass, macromolecular content and pressure in major limb joints of the rabbit.

Authors:  P Knox; J R Levick; J N McDonald
Journal:  Q J Exp Physiol       Date:  1988-01

Review 5.  Role of proinflammatory cytokines in the pathophysiology of osteoarthritis.

Authors:  Mohit Kapoor; Johanne Martel-Pelletier; Daniel Lajeunesse; Jean-Pierre Pelletier; Hassan Fahmi
Journal:  Nat Rev Rheumatol       Date:  2010-11-30       Impact factor: 20.543

Review 6.  Cytokine targeting in osteoarthritis.

Authors:  Arjen B Blom; Peter M van der Kraan; Wim B van den Berg
Journal:  Curr Drug Targets       Date:  2007-02       Impact factor: 3.465

7.  Comparison of synovial tissues from the knee joints and the small joints of rheumatoid arthritis patients: Implications for pathogenesis and evaluation of treatment.

Authors:  Maarten C Kraan; Richard J Reece; Tom J M Smeets; Douglas J Veale; Paul Emery; Paul P Tak
Journal:  Arthritis Rheum       Date:  2002-08

Review 8.  New developments in osteoarthritis. Posttraumatic osteoarthritis: pathogenesis and pharmacological treatment options.

Authors:  Martin K Lotz; Virginia B Kraus
Journal:  Arthritis Res Ther       Date:  2010-06-28       Impact factor: 5.156

9.  Inflammatory mediators in posttraumatic radiocarpal osteoarthritis.

Authors:  T Teunis; M Beekhuizen; M Kon; L B Creemers; A H Schuurman; L P van Minnen
Journal:  J Hand Surg Am       Date:  2013-08-06       Impact factor: 2.230

Review 10.  Osteoarthritis: can anti-cytokine therapy play a role in treatment?

Authors:  Ana Luisa G Calich; Diogo S Domiciano; Ricardo Fuller
Journal:  Clin Rheumatol       Date:  2010-01-27       Impact factor: 2.980

View more
  10 in total

1.  Anatomically shaped tissue-engineered cartilage with tunable and inducible anticytokine delivery for biological joint resurfacing.

Authors:  Franklin T Moutos; Katherine A Glass; Sarah A Compton; Alison K Ross; Charles A Gersbach; Farshid Guilak; Bradley T Estes
Journal:  Proc Natl Acad Sci U S A       Date:  2016-07-18       Impact factor: 11.205

2.  Influence of IL13 on Periostin Secretion by Synoviocytes in Osteoarthritis.

Authors:  Tatsuya Moue; Yutaro Tajika; Shintaro Ishikawa; Yasuaki Kanada; Takayuki Okumo; Kazuhito Asano; Tadashi Hisamitsu
Journal:  In Vivo       Date:  2017-01-02       Impact factor: 2.155

3.  Functional tissue engineering of articular cartilage for biological joint resurfacing-The 2021 Elizabeth Winston Lanier Kappa Delta Award.

Authors:  Farshid Guilak; Bradley T Estes; Franklin T Moutos
Journal:  J Orthop Res       Date:  2021-12-06       Impact factor: 3.102

4.  Deficiency of hyaluronan synthase 1 (Has1) results in chronic joint inflammation and widespread intra-articular fibrosis in a murine model of knee joint cartilage damage.

Authors:  D D Chan; W F Xiao; J Li; C A de la Motte; J D Sandy; A Plaas
Journal:  Osteoarthritis Cartilage       Date:  2015-11       Impact factor: 6.576

Review 5.  The interrelation of osteoarthritis and diabetes mellitus: considering the potential role of interleukin-10 and in vitro models for further analysis.

Authors:  Silke Schwarz; Ingo Mrosewski; Sandeep Silawal; Gundula Schulze-Tanzil
Journal:  Inflamm Res       Date:  2017-12-01       Impact factor: 4.575

6.  Efficacy of arthrocentesis and lavage for treatment of post-traumatic arthritis in temporomandibular joints.

Authors:  Joo-Young Park; Jong-Ho Lee
Journal:  J Korean Assoc Oral Maxillofac Surg       Date:  2020-06-30

7.  Characterization of the interleukin-17 effect on articular cartilage in a translational model: an explorative study.

Authors:  Anne-Christine Bay-Jensen; Patrik Önnerfjord; Dovile Sinkeviciute; Anders Aspberg; Yi He
Journal:  BMC Rheumatol       Date:  2020-05-12

8.  An Evidence-Based Systematic Review of Human Knee Post-Traumatic Osteoarthritis (PTOA): Timeline of Clinical Presentation and Disease Markers, Comparison of Knee Joint PTOA Models and Early Disease Implications.

Authors:  Christine M Khella; Rojiar Asgarian; Judith M Horvath; Bernd Rolauffs; Melanie L Hart
Journal:  Int J Mol Sci       Date:  2021-02-17       Impact factor: 5.923

9.  Circulating levels of proinflammatory mediators as potential biomarkers of post-traumatic knee osteoarthritis development.

Authors:  Svetlana B Panina; Igor V Krolevets; Natalia P Milyutina; Alexander B Sagakyants; Igor V Kornienko; Anzhelika A Ananyan; Mikhail A Zabrodin; Andrey A Plotnikov; Valeriy V Vnukov
Journal:  J Orthop Traumatol       Date:  2017-10-20

10.  A roadmap to target interleukin-6 in osteoarthritis.

Authors:  Renske Wiegertjes; Fons A J van de Loo; Esmeralda N Blaney Davidson
Journal:  Rheumatology (Oxford)       Date:  2020-10-01       Impact factor: 7.580

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.